Literature DB >> 6752316

Comparison of five assays for immune complexes in the rheumatic diseases: performance characteristics of the assays.

J S McDougal, M Hubbard, P L Strobel, F C McDuffie.   

Abstract

The BCA, the 125-C1qBA, the mRF inhibition assay, Raji cell assay, and the SBA, all assays for ICs, were evaluated for their performance characteristics on the same specially prepared samples (267 sera), and results were compared by reference to a common standard. Differences in reproducibility between the tests were relatively consistent regardless of the parameter of variation examined or the internal standard used to compute results (overall rank order of variation: BCA and SBA less than C1qBA and Raji less than mRF). Larger ICs were overestimated and smaller ICs were underestimated by the assays. Intermediate (11s to 19s) complexes were detected by all the assays, but there were marked differences in sensitivity for this material (SBA greater than mRF greater than BCA greater than Raji greater than C1qBA). The correlation of IC assay results with IgG levels in clinical specimens could not be reproduced in vitro with monomeric IgG, and thus an artifactual influence of IgG levels on IC assay readouts was not the primary reason for this correlation. All assays were influenced by the presence of IgM rheumatoid factors. The effect of other serum manipulations such as polyanions, anticoagulants, and variation in complement could have been predicted from the receptor principle of each assay.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6752316

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  3 in total

1.  Evaluation of plasma C3d and immune complex determinations in the assessment of disease activity of patients with rheumatoid arthritis, systemic lupus erythematosus, and spondylitis ancylopoetica.

Authors:  P B Krauledat; F E Krapf; B Manger; J R Kalden
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

2.  Immune complexes in the acquired immunodeficiency syndrome (AIDS): relationship to disease manifestation, risk group, and immunologic defect.

Authors:  J S McDougal; M Hubbard; J K Nicholson; B M Jones; R C Holman; J Roberts; D B Fishbein; H W Jaffe; J E Kaplan; T J Spira
Journal:  J Clin Immunol       Date:  1985-03       Impact factor: 8.317

3.  Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis.

Authors:  Tomas Weitoft; Johan Rönnelid; Azita Sohrabian; Linda Mathsson-Alm; Monika Hansson; Ann Knight; Jörgen Lysholm; Martin Cornillet; Karl Skriner; Guy Serre; Anders Larsson
Journal:  Ann Rheum Dis       Date:  2018-06-12       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.